Central Drugs Standard Control Organisation

Russian Phase-3 trial data enough for nod to Sputnik Light: SEC | India News

HYDERABAD: In a significant development that could speed up the rollout of the single-dose Russian vaccine Sputnik Light in India, the subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has told Dr Reddy’s Laboratories that it does not need to conduct a separate Phase-III trial in India for the vaccine as …

Russian Phase-3 trial data enough for nod to Sputnik Light: SEC | India News Read More »

In a first, 5 Indian pharma majors ally for Covid drug trials | India News

HYDERABAD: In a first, five Indian pharma majors have joined hands to conduct phase-III clinical trials of investigational anti-viral drug Molnupiravir on mild Covid-19 patients. The companies include Dr Reddy’s Laboratories Ltd, Cipla Ltd, Sun Pharmaceutical Industries Ltd, Torrent Pharmaceuticals Ltd and Emcure Pharmaceuticals Ltd. The companies have entered into a collaboration agreement, as part …

In a first, 5 Indian pharma majors ally for Covid drug trials | India News Read More »

Cipla gets nod to import Moderna COVID-19 vaccine in India

Moderna has also informed that the U.S. government has agreed to donate to India a certain number of doses of the Moderna vaccine through COVAX Cipla Ltd. on Tuesday received approval from the country’s drugs regulator to import the COVID-19 vaccine developed by Moderna Inc. for restricted emergency use. Niti Ayog member (Health) V.K. Paul …

Cipla gets nod to import Moderna COVID-19 vaccine in India Read More »

Cipla gets DCGI nod to import Moderna’s Covid vaccine for restricted emergency use in India: Sources | India News

NEW DELHI: India’s drug regulator DCGI has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna‘s Covid-19 vaccine for restricted emergency use in the country, official sources said on Tuesday. Moderna’s vaccine will be the fourth Covid-19 jab to be available in India after Covishield, Covaxin and Sputnik. “Drugs Controller General of India (DCGI) …

Cipla gets DCGI nod to import Moderna’s Covid vaccine for restricted emergency use in India: Sources | India News Read More »

Moderna seeks regulatory approval for its COVID-19 vaccine

Mumbai-based pharmaceutical firm Cipla, on behalf of the U.S. pharma major, has requested for import and marketing authorisation of these jabs India’s drug regulator may soon grant restricted emergency use authorisation for Moderna’s COVID-19 vaccine, official sources said on June 29. Moderna has also informed that the U.S. Government has agreed to donate a certain …

Moderna seeks regulatory approval for its COVID-19 vaccine Read More »